MBC-11 trisodium
MBC-11 trisodium is a novel bone-targeting conjugate designed for research into tumor-induced bone disease (TIBD) . It combines the bisphosphonate HEDP with the antimetabolite Ara-C, enabling localized delivery to bone metastases. This construct is utilized in preclinical in vitro and in vivo studies investigating targeted therapies for osteolytic cancers.
Product Specifications
CAS Number
387877-45-4
Field of Research
Cell Biology
Smiles
[Na].[H][C@]1 (O[C@H] (COP (O) (=O) OP (O) (=O) C (C) (O) P (O) (O) =O) [C@@H] (O) [C@@H]1O) n1ccc (N) nc1=O
Molecular Formula
C11H17N3Na3O14P3
Molecular Weight
577.16
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS637889-01 0.01 mg
CD40L, Soluble, Recombinant, Human (ACRP30headless:CD40L, ACRP30headless:CD154, ACRP30headless:TNFSF5, ADIPOQ-CD40L)
Sign In for Pricing
View Details MBS637889-02 5x 0.01 mg
CD40L, Soluble, Recombinant, Human (ACRP30headless:CD40L, ACRP30headless:CD154, ACRP30headless:TNFSF5, ADIPOQ-CD40L)
Sign In for Pricing
View Details 
P9102-91L4-AP 200 µL
PRKAR1B, NT (cAMP-dependent Protein Kinase Type I-beta Regulatory Subunit) (AP) discontinued
Sign In for Pricing
View Details MBS6485834-01 0.1 mL
Macrophage Inflammatory Protein 1 alpha (MIP-1-alpha, MIP1A, C-C Motif Chemokine 3, CCL3, Chemokine (C-C Motif) Ligand 3, G0/G1 Switch Regulatory Protein 19-1, G0S19-1, LD78ALPHA, PAT 464.1, SIS-beta, Small-inducible Cytokine A3, SCYA3, Tonsillar Lymphocy
Sign In for Pricing
View Details MBS6485834-02 5x 0.1 mL
Macrophage Inflammatory Protein 1 alpha (MIP-1-alpha, MIP1A, C-C Motif Chemokine 3, CCL3, Chemokine (C-C Motif) Ligand 3, G0/G1 Switch Regulatory Protein 19-1, G0S19-1, LD78ALPHA, PAT 464.1, SIS-beta, Small-inducible Cytokine A3, SCYA3, Tonsillar Lymphocy
Sign In for Pricing
View Details